These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 20713790)

  • 1. Steroid pretreatment of organ donors to prevent postischemic renal allograft failure: a randomized, controlled trial.
    Kainz A; Wilflingseder J; Mitterbauer C; Haller M; Burghuber C; Perco P; Langer RM; Heinze G; Oberbauer R
    Ann Intern Med; 2010 Aug; 153(4):222-30. PubMed ID: 20713790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantation with kidneys retrieved from deceased donors with acute renal failure.
    Klein R; Galante NZ; de Sandes-Freitas TV; de Franco MF; Tedesco-Silva H; Medina-Pestana JO
    Transplantation; 2013 Feb; 95(4):611-6. PubMed ID: 23274968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of N-acetylcysteine pretreatment of deceased organ donors on renal allograft function: a randomized controlled trial.
    Orban JC; Quintard H; Cassuto E; Jambou P; Samat-Long C; Ichai C
    Transplantation; 2015 Apr; 99(4):746-53. PubMed ID: 25250647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cyclosporine A pretreatment of deceased organ donors on kidney graft function (Cis-A-rein): study protocol for a randomized controlled trial.
    Orban JC; Fontaine E; Cassuto E; Baumstarck K; Leone M; Constantin JM; Ichai C;
    Trials; 2018 Apr; 19(1):231. PubMed ID: 29665840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Deceased Donor Acute Kidney Injury With Recipient Graft Survival.
    Liu C; Hall IE; Mansour S; Thiessen Philbrook HR; Jia Y; Parikh CR
    JAMA Netw Open; 2020 Jan; 3(1):e1918634. PubMed ID: 31913491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid pretreatment of organ donors does not impact on early rejection and long-term kidney allograft survival: Results from a multicenter randomized, controlled trial.
    Reindl-Schwaighofer R; Kainz A; Jelencsics K; Heinzel A; Berlakovich G; Remport Á; Heinze G; Langer R; Oberbauer R
    Am J Transplant; 2019 Jun; 19(6):1770-1776. PubMed ID: 30614649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial.
    Schnuelle P; Gottmann U; Hoeger S; Boesebeck D; Lauchart W; Weiss C; Fischereder M; Jauch KW; Heemann U; Zeier M; Hugo C; Pisarski P; Krämer BK; Lopau K; Rahmel A; Benck U; Birck R; Yard BA
    JAMA; 2009 Sep; 302(10):1067-75. PubMed ID: 19738091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of steroid pretreatment of deceased organ donors on liver allograft function: a blinded randomized placebo-controlled trial.
    Amatschek S; Wilflingseder J; Pones M; Kainz A; Bodingbauer M; Mühlbacher F; Langer RM; Gerlei Z; Oberbauer R
    J Hepatol; 2012 Jun; 56(6):1305-9. PubMed ID: 22326464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful transplantation of kidneys from deceased donors with acute renal failure: Three-year results.
    Anil Kumar MS; Khan SM; Jaglan S; Heifets M; Moritz MJ; Saeed MI; Fyfe B; Sustento-Reodica N; Kumar A
    Transplantation; 2006 Dec; 82(12):1640-5. PubMed ID: 17198251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Declined Offers of Deceased Donor Kidney Allograft and Outcomes in Kidney Transplant Candidates.
    Husain SA; King KL; Pastan S; Patzer RE; Cohen DJ; Radhakrishnan J; Mohan S
    JAMA Netw Open; 2019 Aug; 2(8):e1910312. PubMed ID: 31469394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantation.
    Collins MG; Fahim MA; Pascoe EM; Dansie KB; Hawley CM; Clayton PA; Howard K; Johnson DW; McArthur CJ; McConnochie RC; Mount PF; Reidlinger D; Robison L; Varghese J; Vergara LA; Weinberg L; Chadban SJ;
    Trials; 2020 May; 21(1):428. PubMed ID: 32450917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Kidney transplantation from Covid-19 positive deceased donor: what are the consequences for recipients?].
    Perlin DV; Alexandrov IV; Shmanev AO; A TV; Perlina AV
    Urologiia; 2021 Sep; (4):87-92. PubMed ID: 34486280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothermia for expanded criteria organ donors in kidney transplantation in France (HYPOREME): a multicentre, randomised controlled trial.
    HYPOREME Trial Group
    Lancet Respir Med; 2024 Sep; 12(9):693-702. PubMed ID: 38876137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful kidney transplantation from a cadaveric donor unsuitable for other centers due to acute renal failure: a case report.
    Bilgic A; Erdogan B; Kali A; Buyukbakkal M; Eser B; Bozkurt B; Kilic M; Ayli MD
    Transplant Proc; 2012; 44(6):1764-6. PubMed ID: 22841267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double versus single renal allografts from aged donors.
    Andrés A; Morales JM; Herrero JC; Praga M; Morales E; Hernández E; Ortuño T; Rodício JL; Martínez MA; Usera G; Díaz R; Polo G; Aguirre F; Leiva O
    Transplantation; 2000 May; 69(10):2060-6. PubMed ID: 10852597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk for Delayed Graft Function in Deceased Donor Renal Transplant Patients: A Single-Center Experience From North India.
    Seth A; Sharma A; Kenwar DB; Patil SS; Pandey GS; Kallepalli V; Rally S; Thakur V; Mandwar M; Singh S
    Transplant Proc; 2020; 52(6):1741-1743. PubMed ID: 32434744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of kidney transplants from non-heart-beating deceased donors as reported to the Japan Organ Transplant Network from April 1995-December 2003: a multi-center report.
    Teraoka S; Nomoto K; Kikuchi K; Hirano T; Satomi S; Hasegawa A; Uchida K; Akiyama T; Tanaka S; Babazona T; Shindo K; Nakamura N
    Clin Transpl; 2004; ():91-102. PubMed ID: 16704141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute renal failure in renal allograft recipients and patients with native kidneys.
    Carvalho MF; Barretti P; Inuzuka LM; Sueto M; Nishimura MR; Caramori JC; Balbi AL; Corrêa LA; Soares VA
    Ren Fail; 1997 Mar; 19(2):259-65. PubMed ID: 9101601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.